Guardant Health Quarterly Income Statement
NASDAQ: GHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Guardant Health revenue and earnings
In the quarter ended Jun 30, 2026, Guardant Health generated $335.0 million in revenue, up 44.3% from the same quarter a year earlier. Guardant Health reported a net loss of $120.1 million, compared with a loss of $99.9 million a year earlier. Gross margin was 65.4% (up from 65.0%) and operating margin -38.5%.
Diluted earnings per share came in at -$0.90.
Summary generated from market data by MetaCap's automated system. Methodology
Guardant Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 334.98M | 301.67M | 281.27M | 265.20M | 232.09M | 203.47M | 201.81M | 191.48M | 177.24M | 168.49M | 155.05M | 143.03M |
| Revenue growth (YoY) | +44.33% | +48.26% | +39.37% | +38.50% | +30.95% | +20.76% | +30.16% | +33.87% | +29.23% | +30.90% | +22.19% | +21.83% |
| Cost of Revenue | 115.95M | 104.92M | 99.49M | 93.59M | 81.20M | 74.72M | 77.59M | 74.49M | 72.42M | 65.30M | — | — |
| Gross Profit | 219.03M | 196.75M | 181.77M | 171.61M | 150.88M | 128.75M | 124.22M | 116.99M | 104.81M | 103.19M | — | — |
| Operating Expenses | 348.15M | 318.10M | 302.58M | 270.60M | 257.30M | 239.79M | 250.19M | 234.31M | 205.43M | 202.88M | — | — |
| Research & Development | 96.53M | 91.04M | 98.26M | 89.96M | 87.45M | 88.52M | 93.54M | 87.31M | 83.10M | 83.80M | 89.86M | 93.85M |
| Selling, General & Admin | 251.61M | 227.06M | 204.31M | 180.64M | 169.85M | 151.27M | 156.64M | 147.01M | 122.33M | 119.08M | 116.79M | 105.11M |
| Operating Income | -129.12M | -121.35M | -120.81M | -98.99M | -106.41M | -111.04M | -125.97M | -117.33M | -100.62M | -99.68M | -197.51M | -113.54M |
| Interest Expense | 1.35M | 1.35M | 1.18M | 943.00K | 983.00K | 791.00K | 645.00K | 646.00K | 645.00K | 645.00K | 645.00K | 644.00K |
| Other Income (Expense) | 308.00K | -157.00K | -18.27M | -48.00K | -25.00K | 7.85M | 4.67M | -3.01M | -15.14M | -29.12M | -3.32M | 16.89M |
| Pretax Income | -119.96M | -111.70M | -130.22M | -92.59M | -99.86M | -94.87M | -110.29M | -107.72M | -102.50M | -114.58M | -187.58M | -85.61M |
| Income Tax | 185.00K | 372.00K | -1.73M | 136.00K | 38.00K | 290.00K | 716.00K | 30.00K | 133.00K | 405.00K | -541.00K | 490.00K |
| Net Income | -120.14M | -112.08M | -128.49M | -92.72M | -99.90M | -95.16M | -111.01M | -107.75M | -102.63M | -114.98M | -187.04M | -86.10M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.90 | -0.85 | -1.01 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| EPS (Diluted) | -0.90 | -0.85 | -1.01 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| Shares Outstanding (Basic) | 132.87M | 131.27M | — | 124.81M | 124.11M | 123.87M | — | 123.05M | 122.45M | 121.71M | — | 117.74M |
| Shares Outstanding (Diluted) | 132.87M | 131.27M | — | 124.81M | 124.11M | 123.87M | — | 123.05M | 122.45M | 121.71M | — | 117.74M |
| EBITDA | -119.56M | -111.91M | -110.75M | -89.58M | -96.37M | -100.81M | -115.51M | -106.73M | -90.00M | -88.97M | -186.64M | -102.51M |
| Gross Margin | 65.39% | 65.22% | 64.63% | 64.71% | 65.01% | 63.28% | 61.55% | 61.10% | 59.14% | 61.25% | — | — |
| Operating Margin | -38.55% | -40.23% | -42.95% | -37.33% | -45.85% | -54.57% | -62.42% | -61.28% | -56.77% | -59.16% | -127.38% | -79.38% |
| Net Margin | -35.87% | -37.15% | -45.68% | -34.96% | -43.04% | -46.77% | -55.00% | -56.28% | -57.91% | -68.24% | -120.63% | -60.20% |
This table shows 12 quarterly periods of Guardant Health's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow GH's reporting calendar. What is a income statement?